These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8787090)

  • 1. [Platelet antiaggregants and atheromatous arteriopathy of the lower limbs].
    Lévesque H; Cailleux N; Courtois H
    Rev Med Interne; 1996; 17(2):163-8. PubMed ID: 8787090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6922):159-68. PubMed ID: 8312766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of major ischemic events in lower limb arterial disease: does aspirin play a role?].
    Lechat P; Priollet P
    J Mal Vasc; 2006 Jul; 31(3):129-34. PubMed ID: 16840949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antiplatelet drugs in the prevention of cardiovascular events.
    Tendera M; Wojakowski W
    Thromb Res; 2003 Jun; 110(5-6):355-9. PubMed ID: 14592562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When do vascular surgeons prescribe antiplatelet therapy? Current attitudes.
    Sarin S; Shami SK; Cheatle TR; Bearn P; Scurr JH; Coleridge Smith PD
    Eur J Vasc Surg; 1993 Jan; 7(1):6-13. PubMed ID: 8454081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of peripheral arterial disease.
    Hilleman DE
    Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S21-7. PubMed ID: 9784799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
    Dörffler-Melly J; Schmidli J; Mahler F
    Ther Umsch; 2003 Jan; 60(1):36-42. PubMed ID: 12638477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
    Violi F; Balsano F
    Clin Trials Metaanal; 1994 Apr; 29(1):81-7. PubMed ID: 10150187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients.
    Hacke W
    Cerebrovasc Dis; 2002; 13 Suppl 1():22-6. PubMed ID: 11803184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Sobel M; Verhaeghe R
    Chest; 2008 Jun; 133(6 Suppl):815S-843S. PubMed ID: 18574279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel: a review of its use in the prevention of atherothrombosis.
    Jarvis B; Simpson K
    Drugs; 2000 Aug; 60(2):347-77. PubMed ID: 10983738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone].
    MMW Fortschr Med; 2004; 146 Suppl 1():4-5. PubMed ID: 15493408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.